Fingerprint
Dive into the research topics of 'Imatinib Optimized Therapy Improves Major Molecular Response Rates in Patients with Chronic Myeloid Leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Imatinib Optimized Therapy Improves Major Molecular Response Rates in Patients with Chronic Myeloid Leukemia
Groupe Français pour la LMC (Fi-LMC)
- Department of Hematology (S.G.)
- Centre Hospitalier de Versailles
- Ctr Hosp Pontchaillou, Centre Hospitalier Universitaire de Rennes, Serv Hematol Clin
- Centre Hospitalier Annecy Genevois
- Centre Hospitalier de Dieppe
- CHU Poitiers
- Centre Hospitalier Pellegrin-Tripode
- Unité de Recherche Clinique et Département de Santé Publique
- Unité 353 INSERM, Hôpital Saint Louis, Paris, France.
Research output: Contribution to journal › Article › peer-review
6
Citations
(Scopus)